FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Accelerated Approval for Bayer Kinase Inhibitor

[ Price : $8.95]

FDA grants accelerated approval to Bayer Healthcare Pharmaceuticals Aliqopa (copanlisib) for treating adults with relapsed follicu...

Organ Preservation Device Guidance Out

[ Price : $8.95]

FDA issues a draft guidance on its current thoughts on how animal transplant models can be used to evaluate organ preservation tec...

FDA is Being Flexible in Fast Track Approvals: Post

[ Price : $8.95]

Hyman, Phelps & McNamara attorneys say that since 2015 FDA has been demonstrating flexibility leading to increased fast track appr...

Draft Guide on Microdose Radiopharmaceutical Diagnostic Drugs

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Microdose Radiopharmaceutical Diagnostic Drugs: Nonclinical...

Medtronic Recalls Infusion Sets Due to Defective Component

[ Price : $8.95]

Medtronic recalls several lots of infusion sets used with all models of Medtronic insulin pumps due to a defective vent membrane.

3 Charged in Fake Prescription Drug Lab Case

[ Price : $8.95]

The FDA Office of Criminal Investigations says three Florida residents have been charged in connection with importing, manufacturi...

FDA Accepts Astellas sNDA for Overactive Bladder Drug Combo

[ Price : $8.95]

FDA accepts for review an Astellas Pharma supplemental NDA that seeks approval for the use of mirabegron in combination with solif...

Agilent GenetiSure Dx Postnatal Assay Cleared

[ Price : $8.95]

FDA clears an Agilent Technologies 510(k) for the GenetiSure Dx Postnatal Assay, a comparative genomic hybridization assay for dia...

Class 1 Recall of Leonard Lang Defibrillation Electrodes

[ Price : $8.95]

FDA rates as Class 1 a Leonard Lang recall of two Skintact multifunction defibrillation electrode models due to a connector compat...

Wound-Healing Study Misses Endpoints

[ Price : $8.95]

Amicus Therapeutics says top-line Phase 3 ESSENCE study data show its SD-101 wound-healing agent did not meet primary or secondary...